Navigation Links
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/17/2011

view 35

4.2 5.1.1 Strategic Competitor Assessment 35

4.3 Product Profiles for the Major Marketed Products in the Influenza Vaccines Market 36

4.3.1 Fluarix 36

4.3.2 FluLaval 37

4.3.3 Flumist 38

4.3.4 Fluvirin 39

4.3.5 Fluzone 39

4.4 Key Takeaway 40

5 Influenza Vaccines - Pipeline Assessment 41

5.1 Overview 41

5.2 Strategic Pipeline Assessment 41

5.2.1 Influenza Vaccines Pipeline – Pipeline by Phases of Development 42

5.2.2 Influenza Vaccines – Regulatory Filed Products 42

5.2.3 Influenza Vaccines – Phase III Pipeline 43

5.2.4 Influenza Vaccines – Phase II Pipeline 43

5.2.5 Influenza Vaccines – Phase I Pipeline 44

5.2.6 Influenza Vaccines – Pre-Clinical Pipeline 45

5.2.7 Influenza Vaccines – Discovery Pipeline 46

5.2.8 Technology Trends Analytical Framework 47

5.3 Influenza Vaccines – Clinical Pipeline by Types of Vaccine 49

5.4 Influenza Vaccines – Promising Drugs Under Clinical Development 49

5.5 Molecule Profile for Promising Drugs Under Clinical Development 50

5.5.1 FluBlok 50

5.5.2 Flu Vaccine 51

5.5.3 MEDI 3250 51

5.5.4 A-04-01D Vaccine 52

5.5.5 H5N1 Pandemic Influenza Vaccine 52

5.5.6 Vepacel 52

5.6 Key Takeaway 52

6 Influenza Vaccines: Clinical Trials Mapping 53

6.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 53

6.2 Clinical Trials by Phase 54

6.3 Clinical Trials by Trial Status 55

6.4 Prominent Sponsors 56

6.5 Top Companies Participating in Influenza Vaccines Clinical Trials 58

7 Influenza Vaccines: Strategic Assessment 59

7.1 Key Events Impacting the Future Market 59

7.2 Influenza Vaccines: Implications for Future Market Competition 60

8 Influenza Vaccines: Future Players 61

8.1 Introduction 61

8.2 Company Pr
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. GSK Begins Shipments of Fluarix(R) and FluLaval(R) to U.S. Customers for 2008-2009 Influenza Season
2. Canopus Biopharma and Leading Chinese Researcher Team Up to Treat Avian Influenza, to Prevent Possible Pandemic
3. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
4. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
5. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
6. Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
7. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
8. Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
10. A New Way to Predict Outbreaks: Replikin Peptide Concentration in H5N1 Influenza Virus Genome as a Marker for Lethal Outbreaks
11. Lentigen Corporation and PATH Announce Partnership on Innovative Vaccine for Pandemic Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... and RARITAN, N.J. , May ... open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) trial ... human anti-CD38 monoclonal antibody – achieved an overall ... 20.8-38.9), as assessed by an independent review committee, ... ORR was consistent among the pre-specified subgroups based ...
(Date:5/29/2015)... Norway , May 29, 2015 ... biopharmaceutical company, today announces that an abstract on the ... molecule inhibitor of the Axl receptor tyrosine kinase, and ... at BerGenBio, has been published in conjunction with the ... in Chicago , May 29 - ...
(Date:5/29/2015)... Market Publishers Ltd and Shanghai ... partnership agreement for quality market research promotion on ... sell research reports worked out by Chem-Report. , ... upon the agreement: “Chem-Report is a Chinese company ... chemical markets on global and country levels. The ...
(Date:5/29/2015)... May 29, 2015  Caris Life Sciences ® ... the promise of precision medicine, today announced the ... the clinical utility of Caris Molecular Intelligence ® ... in helping to identify targeted treatment options for ... of the studies, results of which are to ...
Breaking Biology Technology:Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 2BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6
... and the Institute of Quantum Electronics at ETH Zurich ... understand and predict the properties of both conventional and ... , The lasers that most people are familiar with ... direction that has a well-defined wavelength and a predictable ...
... PALO ALTO, Calif., May 27 CV Therapeutics,Inc. ... clinical abstracts have been,accepted for presentation at the ... be held in San Francisco, CA on June ... Relationship Between Nonfasting Plasma Glucose Concentrations and,Improved ...
... Schering-Plough,Corporation (NYSE: SGP ) today ... vice president, investor relations, effective immediately., ... for developing, implementing,and continually improving a comprehensive ... lead the formulation and execution of,external and ...
Cached Biology Technology:New unifying theory of lasers advanced by physicists 2CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions 2Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations 2
(Date:4/17/2015)... BURNABY, Canada , April 17, 2015 /PRNewswire/ ... projects, growing security concerns, and technological advancement to ... Arabia until 2020   ... " Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric ... is projected to register growth at CAGR ...
(Date:4/13/2015)... NEW YORK , April 13, 2015 /PRNewswire/ ... study by TechSci Research, "Global Biometrics Market Forecast & ... to register a CAGR of around 14% till ... various governments for large scale implementation and review ... technology and launch of new products with greater ...
(Date:4/9/2015)... April 9, 2015 Synaptics Inc. (NASDAQ: SYNA ... today that it will report financial results for the ... 2015, after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2Synaptics to Report Third Quarter Results on April 23 2
... - Researchers are developing new technologies that combine ... and tiny particles such as bacteria, viruses and ... drug manufacturing to food safety. The technologies ... "lab-on-a-chip" applications, or miniature instruments that perform measurements ...
... shown that, from the time that a woman starts trying ... on the time to pregnancy. Professor Roger Hart told ... and Embryology that the negative effect of gum disease on ... effect of obesity. Periodontal (gum) disease is a ...
... to the deserts of East Africa and has unique physical traits ... It has a lack of pain sensation in its skin ... underground with limited oxygen supply. For the first ... understand its longevity and resistance to diseases of ageing. Researchers ...
Cached Biology News:Laser, electric fields combined for new 'lab-on-chip' technologies 2Laser, electric fields combined for new 'lab-on-chip' technologies 3Gum disease can increase the time it takes to become pregnant 2Gum disease can increase the time it takes to become pregnant 3Scientists sequence DNA of cancer-resistant rodent 2
... Rabbit polyclonal to MLF1 Interacting ... for all tested applications). ... corresponding to amino acids 73-83 of ... Entrez Gene ID: 359815 ...
... Nuclease is a genetically engineered endonuclease. This ... and RNA while having no proteolytic activity. ... of conditions and possesses an exceptionally high ... acids from recombinant proteins, its use enables ...
... handy dispensers save space and organize ... other garb. They are the perfect ... used in labs, processing and manufacturing. ... and the particles they attract. Many ...
... Microarrays designed for genome-wide microRNA ... flexible and powerful Paraflo microfluidic on-chip ... as part of our comprehensive microRNA ... Content The Rice microRNA Microarray ...
Biology Products: